Company Overview

Development Stage

About the Company

[Summary] Serve humanity with biotechnology and make human life better.

Wuhan Szybio Shares:
Wuhan Szybio Biotechnology Co., Ltd. was founded in 2009, with its headquarters located in the High-tech Industrial Development Zone - Wuhan · Optics Valley of China. Adhering to the corporate vision of "becoming a globally renowned supplier of life science products and services in the fields of scientific research and diagnostics, continuously creating value for customers, and enabling hardworking employees to live a good life," the company team has united and forged ahead for more than ten years, dedicated to the development of global biotechnology and healthcare as well as strategic investment. At present, the business fields of its subsidiaries cover scientific research reagents, scientific research technical services, diagnostic raw materials, food safety testing reagents, in vitro diagnostic instruments and reagents, and many other fields. It has established a complete industrial chain of raw materials - scientific research & diagnostic reagents - testing services, providing comprehensive services and supporting products for scientific research services, product development, and market applications in the biological field.

In Vitro Diagnostics Business Unit (Wuhan Szybio Biotechnology)
The In Vitro Diagnostics Business Unit of Wuhan Szybio has established four major technology platforms including: biochemistry, chemiluminescence, POCT, and reference laboratories. It has obtained nearly 200 diagnostic reagent product registration certificates, covering multiple testing items such as renal function, liver function, cardiovascular, blood lipids, glucose metabolism, bone metabolism, rheumatism, coagulation, immunity, gastric function, inflammation, pancreas, tumors, special proteins, electrolytes and inorganic ions, and more.

Scientific Research Products Business Unit (Wuhan Huamei Biotechnology)
The Scientific Research Products Business Unit of Wuhan Szybio has now established multiple technology platforms including five major protein expression systems, three major transmembrane protein expression technology platforms, three major antibody discovery platforms, and lead antibody molecule screening. It is committed to providing global customers with high-quality recombinant proteins, monoclonal/polyclonal/recombinant antibodies, ELISA kits, exosome extraction kits, and other biological scientific research reagent products, involving more than ten research fields such as tumors, hormones, autoimmunity, cardiovascular, and metabolism. The number of citations by customers has reached 20,000+.

Industrial Raw Materials Business Unit (Wuhan Huamei Biotechnology)
The Industrial Raw Materials Business Unit of Wuhan Szybio can provide monoclonal antibodies, polyclonal antibodies, diagnostic proteins, biochemical enzymes, molecular biology products, and related customization services. The products comprehensively cover fields such as inflammatory markers, cardiac markers, tumor markers, liver and kidney function, thyroid hormone, autoimmune diseases, respiratory pathogens, and animal infectious diseases; they are widely used in platforms such as immunoturbidimetry, immunochromatography, enzyme-linked immunosorbent assay, chemiluminescence, clinical biochemistry, and molecular diagnostics.

Scientific Research Services Business Unit (Wuhan Jinxiaorui Biotechnology)
The Scientific Research Services Business Unit of Wuhan Szybio has established experimental technology and R&D platforms including: detection and analysis, gene services, protein expression, molecular interaction, antibody preparation, and exosome research. It has supported customers in publishing more than 1,000 scientific research papers, with a cumulative impact factor of 6,000+. The customer groups cover multiple fields such as pharmaceutical enterprises, diagnostic reagent enterprises, scientific research reagent R&D enterprises, universities and research institutes, and large hospitals.

Six insurances and one housing fund, must have!!
High base salary and high commission, must have!!
Online and offline systematic training, excellent sales mentorship, must have!!
Holiday benefits, physical examinations, must have!!
Annual leave and sick leave, paid holidays, must have!!
Dual promotion channels, transparent promotion, many opportunities, must have!!
Professional channel: Sales Representative -- Sales Engineer (Junior, Intermediate, Senior) -- Gold Medal Sales Engineer
Management channel: Sales Representative/Sales Engineer -- Management Reserve Team -- Regional Sales Manager -- Major Regional Sales Manager -- Sales Director
Industry benefits are only standard here!!!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Szybio How Fast Is Hiring Growing? (56 open positions)

Manage
Note: How fast is hiring at Wuhan Szybio Biotechnology Co., Ltd. growing? Szybio2025: 112 openings (up 9%), 2024: 103 openings (down 24%), 2023: 136 openings (up 5%), 2022: 129 openings (up 34%), 2021: 96 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Szybio Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Wuhan Szybio Biotechnology Co., Ltd. growing? SzybioMaster's recruitment over the years: 2025: 40 openings (up 82%), 2024: 22 openings (down 19%), 2023: 27 openings (up 286%), 2022: 7 openings (up 75%), 2021: 4 openings.

Szybio Doctoral Degree Job Demand Analysis

(More)
+50%
Growth Rate
2026 vs 2025
  • 2025: Up 100%
  • 2024: Down 33%
  • 2023: Down 25%
  • 2022: Down 50%
Szybio Doctoral Hiring by Year: 2026 — 2 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Wuhan Szybio Biotechnology Co., Ltd. growing? SzybioDoctorate recruitment over the years: 2026: 6 openings (up 50%), 2025: 4 openings (up 100%), 2024: 2 openings (down 33%), 2023: 3 openings (down 25%), 2022: 4 openings (down 50%), 2021: 8 openings.

Szybio R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Wuhan Szybio Biotechnology Co., Ltd.? Based on an analysis of Szybio's job postings over the past year, "生物/制药/化工/环保类" demand: 23.9%, "其他(研发和技术类)": 23.1%, "科研类": 17.6%, "计算机/网络/技术类": 16.9%, "医疗卫生/美容保健类": 3.1%, "机械/仪器仪表类": 0.4%. For reference only.

Szybio — What Are the Salaries Like? (255 records)

Manage
salary range: 6K - 50K, 60.4% of roles pay ¥10-30K
Note: salary statistics are based on 255 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Wuhan Szybio Biotechnology Co., Ltd.?Szybio60.4% of positions earn 10-30K, Fresh graduate salary: ¥2.5K。Wuhan salary ranking top 45,销售类 average salary ¥14.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Szybio

(More)
Are salaries high at Wuhan Szybio Biotechnology Co., Ltd.? We provide: 销售,研发工程师,大客户,市场,产品经理,信息,技术支持,总经理,研发专家,行政,ba,开发工程师,应用工程师,试剂研发,临床,化学,实习生,技术工程师,算法,软件开发. Click to view detailed salary analysis by job.

Szybio Related Industry Tags

Job Category

  • 销售类
    38.8% of total 38.8%
  • 生物/制药/化工/环保类
    23.9% of total 23.9%
  • 其他(研发和技术类)
    23.1% of total 23.1%
  • 科研类
    17.6% of total 17.6%

Education

  • 本科
    45.1% of total 45.1%
  • 硕士
    31.8% of total 31.8%
  • 大专
    11% of total 11%
  • 不限
    6.7% of total 6.7%

Experience

  • 不限
    38.4% of total 38.4%
  • 1-3年
    22.4% of total 22.4%
  • 3-5年
    21.2% of total 21.2%
  • 5-10年
    17.6% of total 17.6%
View Detailed Analysis

What does Wuhan Szybio Biotechnology Co., Ltd. require? Who is Szybio hiring? Szybio recruitment: 销售类占比最多占38.8%,其次是生物/制药/化工/环保类占23.9%. What education can get in at Szybio? 本科占比最多占45.1%,其次是硕士占31.8%. High education required at Szybio? 硕士占31.8%,博士占3.1%. Work experience required at Szybio? 不限占比最多占38.4%,其次是1-3年占22.4%. Where are the job locations at Szybio? 武汉占比最多占68.2%,其次是北京占8.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,320.2172万(元)
Legal Representative: 华权高
Date Established:
Credit Code: 91420100698327549A
Registered Address: 武汉东湖新技术开发区高新大道818号高科医疗器械园B11号1楼、2楼、3楼

Partners & Suppliers

采购生之源的诊断试剂 Source
合作客户 医疗机构
采购生之源的诊断试剂 Source
合作客户 医疗机构
采购生之源的诊断试剂用于临床检验 Source
合作客户 医疗机构
向生之源供应生物化学试剂和耗材 Source
供应商 医药商业/渠道
向生之源供应生物化学试剂 Source
供应商 医药商业/渠道

People who follow Szybio also follow

Szybio Competitors (Similar Companies)

生物科技/生物工程 生命科学 蛋白表达 抗体
“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
“Committed to providing green, safe, affordable and abundant biopharmac”
“Dedicated to animal health technology to enhance life quality”
医药 生物医药 医药科技 医疗科技
“Global customized services for biological reagents”
生命科学 蛋白表达 抗体 基因工程
“Your professional clinical medical laboratory nearby”
智慧医疗 互联网医疗 医疗信息化 医学影像
伤口护理 医用材料 生物医用材料 医疗器械
“A large private modern pharmaceutical distribution enterprise in China”
科学仪器 生命科学仪器 生命科学 医疗信息化
“Committed to biotechnology development, drug research and development,”
医药 生物制品 生物医药 合成生物学
“Let the light of life science shine into every corner of the earth”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates